BioLife Solutions, Inc. Intangible Assets, Net (Excluding Goodwill)
BioLife Solutions, Inc. (BLFS) had Intangible Assets, Net (Excluding Goodwill) of $3.65 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2026-08-06
- 2026-06-30: Intangible Assets, Net (Excluding Goodwill) $3.65M.
- 2026-03-31: Intangible Assets, Net (Excluding Goodwill) $3.93M.
- 2025-12-31: Intangible Assets, Net (Excluding Goodwill) $4.26M.
- 2025-09-30: Intangible Assets, Net (Excluding Goodwill) $7.45M.
| Period end | Intangible Assets, Net (Excluding Goodwill) | Intangible Assets, Net (Excluding Goodwill) as first filed |
|---|---|---|
| 2026-06-30 | $3.65M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $3.93M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $4.26M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $7.45M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $8.15M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $8.86M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $5.57M 10-K · filed 2026-02-26 | $9.56M 10-K · filed 2025-03-03 |
| 2024-09-30 | $18.41M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $19.32M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $20.23M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $12.00M 10-K · filed 2025-03-03 | $21.15M 10-K · filed 2024-02-29 |
| 2023-09-30 | $22.06M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $29.18M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $30.63M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $32.09M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $74.01M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $76.52M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $149.29M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $152.15M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $155.01M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $148.71M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $30.12M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $31.05M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $19.88M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $20.59M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $21.29M 10-Q · filed 2020-05-29 | |
| 2019-12-31 | $21.98M 10-K · filed 2021-03-31 | |
| 2019-09-30 | $16.05M 10-K · filed 2020-05-15 | $16.48M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $4.02M 10-K · filed 2020-05-15 | $4.45M 10-Q · filed 2019-08-09 |
| 2016-12-31 | $0.00 10-K · filed 2017-03-15 | |
| 2016-09-30 | $2.22M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $2.22M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $2.22M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $2.22M 10-K · filed 2017-03-15 | |
| 2015-09-30 | $2.22M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $2.22M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $2.22M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $2.22M 10-K · filed 2016-02-25 | |
| 2013-12-31 | $0.00 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |